000538 云南白药
已收盘 09-20 15:00:00
资讯
新帖
简况
云南白药:9月19日接受机构调研,招商基金、海通证券参与
证券之星 · 09-20 19:05
云南白药:9月19日接受机构调研,招商基金、海通证券参与
云南白药:9月12日接受机构调研,南方基金、博时基金等多家机构参与
证券之星 · 09-14
云南白药:9月12日接受机构调研,南方基金、博时基金等多家机构参与
云南白药“窝案”后,白云山前董事长李楚源、前董事张春波也遭调查!
市场资讯 · 09-02
云南白药“窝案”后,白云山前董事长李楚源、前董事张春波也遭调查!
换帅之后业绩创历史新高,云南白药做对了什么
证券之星 · 08-31
换帅之后业绩创历史新高,云南白药做对了什么
【工信部到云南白药集团调研】金十数据8月28日讯,据云南白药消息,8月23日,工信部消费品工业司副司长王孝洋一行在云南省工信厅相关负责人的陪同下到云南白药集团调研,进一步了解云南省医药产业发展情况,推动云南省医药产业高质量发展。
美港电讯 · 08-28
【工信部到云南白药集团调研】金十数据8月28日讯,据云南白药消息,8月23日,工信部消费品工业司副司长王孝洋一行在云南省工信厅相关负责人的陪同下到云南白药集团调研,进一步了解云南省医药产业发展情况,推动云南省医药产业高质量发展。
云南白药(000538)2024年中报简析:营收净利润同比双双增长,盈利能力上升
证券之星 · 08-28
云南白药(000538)2024年中报简析:营收净利润同比双双增长,盈利能力上升
云南白药(000538)6月30日股东户数17.71万户,较上期减少8.03%
证券之星 · 08-27
云南白药(000538)6月30日股东户数17.71万户,较上期减少8.03%
图解云南白药中报:第二季度单季净利润同比增13.50%
证券之星 · 08-27
图解云南白药中报:第二季度单季净利润同比增13.50%
云南白药(000538.SZ)发布上半年业绩,净利润31.89亿元,增长12.76%
智通财经 · 08-26
云南白药(000538.SZ)发布上半年业绩,净利润31.89亿元,增长12.76%
云南白药最新公告:上半年净利润同比增长12.76%
证券之星 · 08-26
云南白药最新公告:上半年净利润同比增长12.76%
8月26日云南白药现2302.77万元大宗交易
证券之星 · 08-26
8月26日云南白药现2302.77万元大宗交易
云南白药:本次增持行为不会改变公司无控股股东、实际控制人的局面
证券之星 · 08-09
云南白药:本次增持行为不会改变公司无控股股东、实际控制人的局面
最高增持10亿元!云南白药重返国资控股
市场资讯 · 08-08
最高增持10亿元!云南白药重返国资控股
8月7日云南白药发布公告,其股东增持78.87万股
证券之星 · 08-08
8月7日云南白药发布公告,其股东增持78.87万股
【金十数据整理:亚盘需要关注的个股新闻事件(8月8日)】1. 拓维信息:全资子公司中标中国移动AI服务器采购项目。2. 浙数文化:上半年净利润同比大降76.
美港电讯 · 08-08
【金十数据整理:亚盘需要关注的个股新闻事件(8月8日)】1. 拓维信息:全资子公司中标中国移动AI服务器采购项目。2. 浙数文化:上半年净利润同比大降76.
云南白药,突发!
市场资讯 · 08-07
云南白药,突发!
公告精选丨工业富联:2023年分红总额为115.2亿元;云南白药:第一大股东拟5亿—10亿元继续增持股份
21世纪经济报道 · 08-07
公告精选丨工业富联:2023年分红总额为115.2亿元;云南白药:第一大股东拟5亿—10亿元继续增持股份
8月7日晚间公告 | 云南白药大股东拟增持5-10亿元;鲁北化工上半年净利润超10倍
华尔街见闻 · 08-07
8月7日晚间公告 | 云南白药大股东拟增持5-10亿元;鲁北化工上半年净利润超10倍
云南白药最新公告:第一大股东拟继续增持5亿元-10亿元
证券之星 · 08-07
云南白药最新公告:第一大股东拟继续增持5亿元-10亿元
云南白药(000538.SZ)获第一大股东增持78.87万股 拟累计增持5亿元到10亿元
智通财经 · 08-07
云南白药(000538.SZ)获第一大股东增持78.87万股 拟累计增持5亿元到10亿元
公司概况
公司名称:
云南白药集团股份有限公司
所属行业:
医药制造业
上市日期:
1993-12-15
主营业务:
云南白药集团股份有限公司是一家主要经营化学原料药、化学药制剂、中成药、中药材、生物制品等的公司。公司产品以云南白药系列、三七系列和云南民族特色药品系列为主,共17种剂型200余个产品,产品畅销国内市场及东南亚一带,并逐渐进入日本、欧美等发达国家市场。公司是我国知名中成药生产企业之一,是云南大型工商医药企业之一,是中国中成药五十强之一。2022年12月,由北京大学社会调查研究中心和智联招聘联合主办的“中国年度最佳雇主”评选揭晓,云南白药集团荣膺“2022中国最佳雇主”殊荣。
发行价格:
3.38
{"stockData":{"symbol":"000538","market":"SZ","secType":"STK","nameCN":"云南白药","latestPrice":50.21,"timestamp":1726815801000,"preClose":50.61,"halted":0,"volume":10539660,"delay":0,"floatShares":1769000000,"shares":1784000000,"eps":2.4967,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.4,"latestTime":"09-20 15:00:00","open":50.62,"high":50.7,"low":49.8,"amount":528000000,"amplitude":0.0178,"askPrice":50.25,"askSize":3,"bidPrice":50.21,"bidSize":74,"shortable":0,"etf":0,"ttmEps":2.4967,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1727055000000},"adr":0,"adjPreClose":50.61,"symbolType":"stock","openAndCloseTimeList":[[1726795800000,1726803000000],[1726808400000,1726815600000]],"highLimit":55.67,"lowLimit":45.55,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1784262603,"pbRate":2.29,"roa":"--","roe":"7.93%","epsLYR":2.29,"committee":0.655031,"marketValue":89588000000,"floatMarketCap":88842000000,"peRate":20.110546,"changeRate":-0.0079,"turnoverRate":0.006,"status":1,"nextConnectDate":"根据港交所公布的数据,今日已停止北向交易,下一个交易日为北京时间 2024-09-23。"},"requestUrl":"/m/hq/s/000538/wiki","defaultTab":"wiki","newsList":[{"id":"2468364966","title":"云南白药:9月19日接受机构调研,招商基金、海通证券参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2468364966","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468364966?lang=zh_cn&edition=full","pubTime":"2024-09-20 19:05","pubTimestamp":1726830346,"startTime":"0","endTime":"0","summary":"证券之星消息,2024年9月20日云南白药发布公告称公司于2024年9月19日接受机构调研,招商基金周雨婷 张西林 苏超 王奇玮 李佳存 汪彦初 姚飞军、海通证券张澄参与。2023年,云南白药分红方案为每10股派息20.77元,现金分红总额37.06亿元,占2023年归母净利润比例90.53%,公司已于2024年5月10日完成年度权益分派。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024092000032741.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000538","BK0164","BK0183","BK0012","BK0028","BK0188","BK0239","BK1147","600837","BK0187","06837","BK0070","BK0175","BK0196","BK0276","BK1564"],"gpt_icon":0},{"id":"2467386260","title":"云南白药:9月12日接受机构调研,南方基金、博时基金等多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2467386260","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467386260?lang=zh_cn&edition=full","pubTime":"2024-09-14 06:25","pubTimestamp":1726266330,"startTime":"0","endTime":"0","summary":"证券之星消息,2024年9月13日云南白药发布公告称公司于2024年9月12日接受机构调研,南方基金章晖 郭东谋 卢玉珊 何文欣 秦干一 陈逸、博时基金陈西铭 李佳 张治业、中信建投证券刘若飞 许舒枫参与。白药系列核心产品保持稳健增长,其中云南白药气雾剂销售收入超过12亿元,同比增长超30%,云南白药膏、云南白药胶囊销售收入均保持良好增长。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024091400004884.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000538","BK0164","BK0188","BK0012","BK0028","BK0239","BK0187","BK0175","BK0196"],"gpt_icon":0},{"id":"2464849698","title":"云南白药“窝案”后,白云山前董事长李楚源、前董事张春波也遭调查!","url":"https://stock-news.laohu8.com/highlight/detail?id=2464849698","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2464849698?lang=zh_cn&edition=full","pubTime":"2024-09-02 17:45","pubTimestamp":1725270300,"startTime":"0","endTime":"0","summary":"9月1日晚,白云山又公告称,张春波“因个人原因”,辞去董事等职务,不再担任公司任何职务。 8月30日,据广东省纪委监委官方公众号消息,广州医药集团有限公司原党委书记、董事长李楚源涉嫌严重违纪违法,正接受广东省纪委监委纪律审查和监察调查。李楚源未持有白云山股份,其离任后,副董事长杨军将代为履行董事长职责,直至选举新任董事长。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/s/2024-09-02/doc-incmuhuk1042681.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/s/2024-09-02/doc-incmuhuk1042681.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1606","BK0164","BK0175","BK1521","BK0188","BK0097","00874","BK0187","BK0028","BK0183","BK0196","BK1197","BK0012","BK0096","BK0070","000538","BK1191","600332","BK0239","BK1515"],"gpt_icon":0},{"id":"2463772441","title":"换帅之后业绩创历史新高,云南白药做对了什么","url":"https://stock-news.laohu8.com/highlight/detail?id=2463772441","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2463772441?lang=zh_cn&edition=full","pubTime":"2024-08-31 19:14","pubTimestamp":1725102860,"startTime":"0","endTime":"0","summary":"8月26日,云南白药发布2024年半年度报告,上半年实现营业收入204.55亿元,归母净利润31.89亿元,同比增长12.76%;经营活动现金流净额32.61亿元,同比增长44.82%,业绩创历史新高,交出了令人满意的靓丽答卷。云南白药是有120年历史的老企业,在经济环境下行压力较大的背景下,为什么能够不旦经营业绩创历史新高,还能推动企业实现科技创新驱动的高质量发展转型,云南白药做对了什么?云南白药经营业绩创新高且转型发展顺利,未来可期。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2024083100014053.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0164","BK0175","BK0012","BK0187","BK0188","BK0028","000538","BK0196","BK0239"],"gpt_icon":0},{"id":"2462297459","title":"【工信部到云南白药集团调研】金十数据8月28日讯,据云南白药消息,8月23日,工信部消费品工业司副司长王孝洋一行在云南省工信厅相关负责人的陪同下到云南白药集团调研,进一步了解云南省医药产业发展情况,推动云南省医药产业高质量发展。","url":"https://stock-news.laohu8.com/highlight/detail?id=2462297459","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462297459?lang=zh_cn&edition=full","pubTime":"2024-08-28 19:49","pubTimestamp":1724845764,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK0175","BK0188","BK0164","000538","BK0012","BK0187","BK0239","BK0028","BK0196"],"gpt_icon":0},{"id":"2462630128","title":"云南白药(000538)2024年中报简析:营收净利润同比双双增长,盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2462630128","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462630128?lang=zh_cn&edition=full","pubTime":"2024-08-28 06:13","pubTimestamp":1724796801,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期云南白药发布2024年中报。截至本报告期末,公司营业总收入204.55亿元,同比上升0.72%,归母净利润31.89亿元,同比上升12.76%。本报告期云南白药盈利能力上升,毛利率同比增幅6.32%,净利率同比增幅12.06%。2023年,云南白药分红方案为每10股派息20.77元,现金分红总额37.06亿元,占2023年归母净利润比例90.53%,公司已于2024年5月10日完成年度权益分派。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082800007293.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000538"],"gpt_icon":0},{"id":"2462155695","title":"云南白药(000538)6月30日股东户数17.71万户,较上期减少8.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2462155695","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462155695?lang=zh_cn&edition=full","pubTime":"2024-08-27 17:05","pubTimestamp":1724749502,"startTime":"0","endTime":"0","summary":"证券之星消息,近日云南白药披露,截至2024年6月30日公司股东户数为17.71万户,较3月31日减少1.55万户,减幅为8.03%。在中药行业个股中,云南白药股东户数高于行业平均水平,截至6月30日,中药行业平均股东户数为5.03万户。从股价来看,2024年3月31日至2024年6月30日,云南白药区间涨幅为4.54%,在此期间股东户数减少1.55万户,减幅为8.03%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082700029140.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0187","BK0164","BK0239","BK0012","BK0028","000538","BK0196","BK0188","BK0175"],"gpt_icon":0},{"id":"2462941672","title":"图解云南白药中报:第二季度单季净利润同比增13.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2462941672","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462941672?lang=zh_cn&edition=full","pubTime":"2024-08-27 01:39","pubTimestamp":1724693957,"startTime":"0","endTime":"0","summary":"证券之星消息,云南白药2024年中报显示,公司主营收入204.55亿元,同比上升0.72%;归母净利润31.89亿元,同比上升12.76%;扣非净利润31.35亿元,同比上升14.54%;其中2024年第二季度,公司单季度主营收入96.81亿元,同比下降1.18%;单季度归母净利润14.87亿元,同比上升13.5%;单季度扣非净利润14.45亿元,同比上升8.26%;负债率27.55%,投资收益4.77亿元,财务费用-1.3亿元,毛利率29.3%。财报数据概要请见下图: 以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082700002128.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000538"],"gpt_icon":0},{"id":"2462162499","title":"云南白药(000538.SZ)发布上半年业绩,净利润31.89亿元,增长12.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2462162499","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462162499?lang=zh_cn&edition=full","pubTime":"2024-08-26 22:09","pubTimestamp":1724681379,"startTime":"0","endTime":"0","summary":"智通财经APP讯,云南白药 发布2024年半年度报告,报告期内,公司实现营业收入204.55亿元,同比增长0.72%。实现归属于上市公司股东的净利润31.89亿元,同比增长12.76%。上半年,公司聚焦核心主业,业务结构持续优化,工业收入利润贡献稳步上升。报告期内,公司实现营业收入204.55亿元,较上年同期增长0.72%,其中工业收入占营业收入比重进一步提升至37.41%,较上年同期增长0.49个百分点;工业收入增速达2.05%;工业毛利率67.37%,较上年同期增长3.10个百分点。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1171169.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["000538"],"gpt_icon":0},{"id":"2462990859","title":"云南白药最新公告:上半年净利润同比增长12.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2462990859","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462990859?lang=zh_cn&edition=full","pubTime":"2024-08-26 20:01","pubTimestamp":1724673671,"startTime":"0","endTime":"0","summary":"云南白药公告,2024年上半年公司实现营业收入204.55亿元,同比增长0.72%;归属于上市公司股东的净利润为31.89亿元,同比增长12.76%。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082600029554.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000538"],"gpt_icon":0},{"id":"2462856963","title":"8月26日云南白药现2302.77万元大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2462856963","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462856963?lang=zh_cn&edition=full","pubTime":"2024-08-26 16:36","pubTimestamp":1724661364,"startTime":"0","endTime":"0","summary":"证券之星消息,8月26日云南白药发生大宗交易,交易数据如下:大宗交易成交价格48.51元,相对当日收盘价折价9.97%,成交47.47万股,成交金额2302.77万元,买方营业部为浙商证券股份有限公司义乌江滨北路证券营业部,卖方营业部为中信建投证券股份有限公司杭州庆春路证券营业部。近三个月该股共发生1笔大宗交易,合计成交4747.0手,折价成交1笔。截至2024年8月26日收盘,云南白药报收于53.88元,下跌0.04%,换手率0.39%,成交量6.83万手,成交额3.67亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082600020696.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0196","BK0164","000538","BK0239","BK0012","BK0028","BK0187","BK0175"],"gpt_icon":0},{"id":"2458055927","title":"云南白药:本次增持行为不会改变公司无控股股东、实际控制人的局面","url":"https://stock-news.laohu8.com/highlight/detail?id=2458055927","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458055927?lang=zh_cn&edition=full","pubTime":"2024-08-09 17:05","pubTimestamp":1723194313,"startTime":"0","endTime":"0","summary":"证券之星消息,云南白药08月09日在投资者关系平台上答复投资者关心的问题。本次增持行为不会改变公司无控股股东、实际控制人的局面。上述内容已在公司于2024年8月7日发布的《关于5%以上股东增持公司股份暨后续增持计划的公告》中予以披露。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024080900035205.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000538","BK0239","BK0188","BK0164","BK0196","BK0012","BK0175","BK0187","BK0028"],"gpt_icon":0},{"id":"2457186743","title":"最高增持10亿元!云南白药重返国资控股","url":"https://stock-news.laohu8.com/highlight/detail?id=2457186743","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457186743?lang=zh_cn&edition=full","pubTime":"2024-08-08 20:40","pubTimestamp":1723120800,"startTime":"0","endTime":"0","summary":" 并且,自首次增持之日起的6个月内,国有股权管理公司还将继续增持云南白药股份,计划增持金额为5亿元至10亿元。这一增持意味着国资将再度控股云南白药,而云南白药也或将结束长期无实控人的局面。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/s/2024-08-08/doc-inchxvch3341279.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/s/2024-08-08/doc-inchxvch3341279.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0196","000538","BK0012","BK0239","BK0028","BK0188","BK0175","BK0164","BK0187"],"gpt_icon":0},{"id":"2457351900","title":"8月7日云南白药发布公告,其股东增持78.87万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2457351900","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457351900?lang=zh_cn&edition=full","pubTime":"2024-08-08 15:00","pubTimestamp":1723100449,"startTime":"0","endTime":"0","summary":"证券之星消息,8月7日云南白药发布公告《云南白药:关于5%以上股东增持公司股份暨后续增持计划的公告》,其股东云南省国有股权运营管理有限公司于2024年8月6日合计增持78.87万股,占公司目前总股本的0.0442%,变动期间该股股价上涨0.93%,截止8月6日收盘报51.0元。股东增减持详情见下表:根据云南白药2024年一季报公布的十大股东详情如下:以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024080800024301.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0196","BK0187","BK0188","BK0175","BK0028","BK0164","BK0239","000538"],"gpt_icon":0},{"id":"2457800183","title":"【金十数据整理:亚盘需要关注的个股新闻事件(8月8日)】1. 拓维信息:全资子公司中标中国移动AI服务器采购项目。2. 浙数文化:上半年净利润同比大降76.","url":"https://stock-news.laohu8.com/highlight/detail?id=2457800183","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457800183?lang=zh_cn&edition=full","pubTime":"2024-08-08 08:08","pubTimestamp":1723075718,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["002665","SG9999002463.SGD","BK0132","BK0076","BK0271","BK1506","600280","600157","BK1589","002435","002130","BK0149","LU1497733557.USD","BK0217","BK0065","002405","BK0054","BK0188","BK0181","BK0175","BK0100","LU0516422440.USD","BK0187","LU1064131003.USD","BK0037","LU0149721374.USD","600941","600192","BK0028","BK0136","BK0183","BK0214","600343","BK0239","BK0261","LU1634259557.SGD","600633","LU0516422952.EUR","002261","BK0049","CHL","BK0012","LU1522347837.USD","BK0067","000538","00941","LU1497733631.SGD","80883","BK1521","BK0083"],"gpt_icon":0},{"id":"2457828202","title":"云南白药,突发!","url":"https://stock-news.laohu8.com/highlight/detail?id=2457828202","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457828202?lang=zh_cn&edition=full","pubTime":"2024-08-07 22:56","pubTimestamp":1723042560,"startTime":"0","endTime":"0","summary":" 中药巨头云南白药多年的无实控人状况或将终结。如果后续新华都方面没有相应的同比例增持,则将打破此前其与新华都的相关增持约定,也意味着云南白药或将终结多年的无实际控制人状况,重回云南省国资控股状态。 8月7日,云南白药股价以51.14元报收,当天股价微涨0.27%,市值为912亿元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2024-08-07/doc-inchvwna7366891.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2024-08-07/doc-inchvwna7366891.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["000538","BK0239","BK0188","BK0164","BK0196","BK0012","BK0175","BK0187","BK0028"],"gpt_icon":0},{"id":"2457841943","title":"公告精选丨工业富联:2023年分红总额为115.2亿元;云南白药:第一大股东拟5亿—10亿元继续增持股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2457841943","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457841943?lang=zh_cn&edition=full","pubTime":"2024-08-07 21:24","pubTimestamp":1723037056,"startTime":"0","endTime":"0","summary":"今日焦点工业富联:2023年分红总额为115.2亿元,每10股派现5.8元工业富联公告实施2023年度分红方案,每10股派现5.8元,分红总额为115.2亿元,分红率达上市以来新高的54.76%。本次权益分派股权登记日为8月14日,除权除息日为8月15日。湘江鲲鹏投标总价为190.6亿元,中标份额为8.77%。项目供货产品为兆瀚系列AI服务器及相关产品,项目尚未签署正式合同,具体内容以最终签订的合同为准。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408072138219f1777ec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408072138219f1777ec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SGXZ49509284.SGD","LU1934453819.USD","LU2495084118.USD","SGXZ81163826.USD","LU1064130708.USD","BK0196","601138","LU1997244956.HKD","LU1997245094.SGD","LU1979443071.USD","BK0187","LU1064131003.USD","LU2289578879.USD","BK0012","LU1655091616.SGD","BK0214","LU2148510915.USD","LU1997245177.USD","BK0188","BK0239","LU0456827905.SGD","LU0051755006.USD","BK0028","BK0175","BK0164","000538"],"gpt_icon":0},{"id":"2457466818","title":"8月7日晚间公告 | 云南白药大股东拟增持5-10亿元;鲁北化工上半年净利润超10倍","url":"https://stock-news.laohu8.com/highlight/detail?id=2457466818","media":"华尔街见闻","labels":["viewpoints"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457466818?lang=zh_cn&edition=full","pubTime":"2024-08-07 20:30","pubTimestamp":1723033817,"startTime":"0","endTime":"0","summary":"3、长白山:2024年上半年净利润同比增长71.70%,因上半年旅游人数增加,因此收入增加。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408072045479585d910&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408072045479585d910&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"viewpoints","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["000538","600727"],"gpt_icon":0},{"id":"2457116813","title":"云南白药最新公告:第一大股东拟继续增持5亿元-10亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457116813","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457116813?lang=zh_cn&edition=full","pubTime":"2024-08-07 18:10","pubTimestamp":1723025442,"startTime":"0","endTime":"0","summary":"云南白药公告,第一大股东国有股权管理公司于2024年8月6日增持云南白药集团股份有限公司78.87万股,其计划自2024年8月6日起6个月内继续增持,累计增持金额不低于5亿元,不超过10亿元。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024080700037968.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0187","BK0028","BK0175","BK0239","BK0188","000538","BK0164","BK0196"],"gpt_icon":0},{"id":"2457881332","title":"云南白药(000538.SZ)获第一大股东增持78.87万股 拟累计增持5亿元到10亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457881332","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457881332?lang=zh_cn&edition=full","pubTime":"2024-08-07 18:09","pubTimestamp":1723025393,"startTime":"0","endTime":"0","summary":"智通财经APP讯,云南白药(000538.SZ)发布公告,公司第一大股东云南省国有股权运营管理有限公司(简称“国有股权管理公司”)于2024年8月6日通过深圳证券交易所交易系统以集中竞价交易方式增持公司股份78.87万股,占公司总股本的比例约为0.0442%,增持金额为4001.68万元。国有股权管理公司自首次增持之日(2024年8月6日)起6个月内计划继续增持公司股份,计划累计增持金额(含本次披露的已增持金额)不低于人民币5亿元,不超过人民币10亿元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1161149.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["000538","BK0239","BK0188","BK0164","BK0196","BK0012","BK0175","BK0187","BK0028"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"1993-12-15","address":"云南省昆明市呈贡区云南白药街3686号","stockEarnings":[{"period":"1week","weight":-0.0079},{"period":"1month","weight":-0.0562},{"period":"3month","weight":-0.0262},{"period":"6month","weight":0.0298},{"period":"1year","weight":-0.0153},{"period":"ytd","weight":0.0606}],"companyName":"云南白药集团股份有限公司","boardCode":"AI0027","perCapita":"9989股","boardName":"医药制造业","registeredCapital":"178426万元","compareEarnings":[{"period":"1week","weight":0.0121},{"period":"1month","weight":-0.0419},{"period":"3month","weight":-0.0872},{"period":"6month","weight":-0.1021},{"period":"1year","weight":-0.1128},{"period":"ytd","weight":-0.08}],"survey":" 云南白药集团股份有限公司是一家主要经营化学原料药、化学药制剂、中成药、中药材、生物制品等的公司。公司产品以云南白药系列、三七系列和云南民族特色药品系列为主,共17种剂型200余个产品,产品畅销国内市场及东南亚一带,并逐渐进入日本、欧美等发达国家市场。公司是我国知名中成药生产企业之一,是云南大型工商医药企业之一,是中国中成药五十强之一。2022年12月,由北京大学社会调查研究中心和智联招聘联合主办的“中国年度最佳雇主”评选揭晓,云南白药集团荣膺“2022中国最佳雇主”殊荣。","serverTime":1726881779597,"listedPrice":3.38,"stockholders":"177126人(较上一季度减少8.03%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.27.0","shortVersion":"4.27.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"云南白药(000538)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供云南白药(000538)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"云南白药,000538,云南白药股票,云南白药股票老虎,云南白药股票老虎国际,云南白药行情,云南白药股票行情,云南白药股价,云南白药股市,云南白药股票价格,云南白药股票交易,云南白药股票购买,云南白药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"云南白药(000538)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供云南白药(000538)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}